Our team has the professional experience to realize that there is no such thing as one-size-fits-all approach to treatment. We are dedicated to meeting your oral health needs at every step of your oncology journey. Team Approach Specialized oral health care begins with understanding your oncolo...
December 10-13, 2024San Antonio, Texas | Virtual/Online Business of MedicineView All Doctors Warm to AI Future in Healthcare, AMA Survey Finds Medscape Medical NewsFebruary 14, 2025 Physicians are increasingly enthusiastic about the future of artificial intelligence (AI) in healthcare generally and...
The surveys were disseminated through various Indian Oncology professional organisation bodies in the country via emails from May 2020 to April 2021. Two survey questionnaires were formulated and validated based on a literature review and input from experts in the fiel...
Click here For HCPs Find more information about our oncology R&D, clinical trial programs, investigator-sponsored studies, IME and CME. Click here Embracing Carers® The Embracing Carers Initiative aims to recognize the role family—or unpaid—carers play in society and support them at each step...
Dental Oncology Professionalsis dedicated to meeting the unique dental and oral health care needs of individuals battling various forms of cancer at all stages. We have experience treating and managing oral side effects and complications that can arise as a result of chemotherapy, radiation therapy, ...
and feeling as if this grief affected the oncologists’ personal relationships negatively. The impact of patient loss on HCPs’ professional behaviors and decisions included focusing on active treatment instead of turning to palliative care, and the tendency to withdraw from patients when they were ne...
Oncology Research 2024 The 4th European Congress on Cancer and Oncology Research was successfully held on October 28-29, 2024, at Rome, Italy, gathering an impressive array of global experts, researchers, healthcare professionals, and industry leaders to discuss the latest trends and innovations in...
Medscape Medical NewsFebruary 24, 2025 PerspectivesView All CDK4/6 Inhibitors in the Treatment of HR+ Breast Cancer Beyond The GuidelinesJanuary 31, 2025 Dr Nancy Nixon comments on how CDK4/6 inhibitors are transforming the treatment of HR-positive breast cancer. ...
Review Article10 Dec 2024 The changing treatment landscape ofEGFR-mutant non-small-cell lung cancer Third-generation EGFR tyrosine-kinase inhibitors (TKIs) are the standard-of-care first-line treatment for patients with advanced-stageEGFR-mutant NSCLC and their efficacy is being investigated in early...
its cutting-edge content, valuable networking opportunities, and a welcoming atmosphere, the congress offers a platform for sharing insights on the latest cancer treatments, enhancing early detection strategies, and fostering collaboration among cancer support groups, all aimed at improving patient care. ...